NASDAQ •
Healthcare •
Biotechnology •
Quote as of 09/16/2026 10:32
Company Profile
IndustryBiotechnology
SectorHealthcare
ExchangeNASDAQ
Market Capitalization8,056.4 mln
Float115 mln
Earnings Date11/11/2026
EPS
9.58
Strong
P / E
2.92
Deeply undervalued
Beneish M-Score
-1.58
Likely manipulated
1-Year Forecast
27.54
Fairly priced
Relative Strength
98
/ 100
Top performer
Debt / Equity
0.77
Moderate leverage
Business Description
Caris Life Sciences is a US-based healthcare company that uses advanced genetic analysis and artificial intelligence to help doctors make better cancer treatment decisions. Founded in 2008 and based in Irving, Texas, the company offers a range of tools that examine tumor and blood samples to identify the molecular characteristics of a patient's cancer. These insights help match patients with the most effective therapies and can even detect cancer at an early stage. Caris also partners with pharmaceutical companies, providing research and data services to support the development of new treatments.
